학술논문

VEGF pathway genetic variants as biomarkers of treatment outcome with bevacizumab: an analysis of data from the AViTA and AVOREN randomised trials
Document Type
Article
Source
In Lancet Oncology July 2012 13(7):724-733
Subject
Primary Research
Articles
Language
ISSN
1470-2045